AI-driven single-cell multiomics aging drug platform
undisclosedDevelop an aging drug platform for precision drug optimisation at the individual level by combining somatic genotype with cellular phenotype at single-cell resolution.
Single-cell multiomics platform using machine learning and AI to integrate somatic genotype and cellular phenotype data.
Company site describes the platform as being built and highlights its application to aging diagnostics and therapeutics tools.
